NCT04198298View on ClinicalTrials.gov

Prospective Clinical Trial of Three Apical Sealing Materials

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

November 2, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Periapical Abscess
Interventions
DRUG

EndoSequence

The EndoSequence® retrograde sealing material was used to provide a biologic seal at the apex.

DRUG

ProRoot MTA

The ProRoot® MTA retrograde sealing material was used to provide a biologic seal at the apex.

DRUG

Biodentine

The Biodentine® retrograde sealing material was used to provide a biologic seal at the apex.

All Listed Sponsors
lead

University of the Pacific

OTHER

NCT04198298 - Prospective Clinical Trial of Three Apical Sealing Materials | Biotech Hunter | Biotech Hunter